Roivant Sciences Ltd. (ROIV)
41.85
+0.66
(+1.60%)
USD |
NASDAQ |
Nov 11, 16:00
41.03
-0.82
(-1.96%)
After-Hours: 20:00
Roivant Sciences Market Cap : 30.29B for Nov. 11, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 11, 2026 | 30.29B |
| November 10, 2026 | 29.81B |
| November 09, 2026 | 29.43B |
| November 06, 2026 | 28.14B |
| November 05, 2026 | 26.50B |
| November 04, 2026 | 27.63B |
| November 03, 2026 | 26.04B |
| November 02, 2026 | 25.94B |
| October 30, 2026 | 26.67B |
| October 29, 2026 | 27.11B |
| October 28, 2026 | 26.82B |
| October 27, 2026 | 26.41B |
| October 26, 2026 | 26.05B |
| October 23, 2026 | 26.37B |
| October 22, 2026 | 27.06B |
| October 21, 2026 | 26.59B |
| October 20, 2026 | 25.24B |
| October 19, 2026 | 25.08B |
| October 16, 2026 | 24.23B |
| October 15, 2026 | 24.60B |
| October 14, 2026 | 24.30B |
| October 13, 2026 | 24.10B |
| October 12, 2026 | 25.00B |
| October 09, 2026 | 25.61B |
| October 08, 2026 | 24.72B |
| Date | Value |
|---|---|
| October 07, 2026 | 25.11B |
| October 06, 2026 | 25.68B |
| October 05, 2026 | 25.86B |
| October 02, 2026 | 25.81B |
| October 01, 2026 | 25.65B |
| September 30, 2026 | 26.43B |
| September 29, 2026 | 26.38B |
| September 28, 2026 | 26.72B |
| September 25, 2026 | 25.87B |
| September 24, 2026 | 26.11B |
| September 23, 2026 | 26.61B |
| September 22, 2026 | 27.62B |
| September 21, 2026 | 28.18B |
| September 18, 2026 | 28.74B |
| September 17, 2026 | 28.89B |
| September 16, 2026 | 28.60B |
| September 15, 2026 | 28.55B |
| September 14, 2026 | 29.64B |
| September 11, 2026 | 29.50B |
| September 10, 2026 | 29.59B |
| September 09, 2026 | 30.21B |
| September 08, 2026 | 29.98B |
| September 04, 2026 | 25.24B |
| September 03, 2026 | 24.87B |
| September 02, 2026 | 24.70B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Bicycle Therapeutics Plc | 186.55M |
| Immunovant, Inc. | 7.659B |
| Adaptimmune Therapeutics Plc | 7.952M |
| Kiniksa Pharmaceuticals International Plc | 7.516B |
| Autolus Therapeutics Plc | 328.93M |
Market Cap Related Metrics
| PS Ratio | 751.97 |
| PEG Ratio | -64.64 |
| Price to Book Value | 7.533 |
| Price | 41.85 |
| Earnings Yield | -1.34% |
| PEGY Ratio | -64.64 |